approval · primary record
RIBOFLAVIN 5'-PHOSPHATE SODIUM
FDA · NDA · 2025-10-17
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Latest action | 2025-10-17 |
| Approval events | 1 |
| Brand | EPIOXA HD/EPIOXA KIT |
| Sponsor | GLAUKOS |
| Route | OPHTHALMIC |
Approval history
1 action on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.
| Date | Agency | Type | Brand | Sponsor | Route |
|---|---|---|---|---|---|
| 2025-10-17 | FDA | NDA | EPIOXA HD/EPIOXA KIT | GLAUKOS | OPHTHALMIC |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-30T00:32:15.407Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: approval:riboflavin-5-phosphate-sodium
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Riboflavin 5'-Phosphate Sodium · compound